More on IDXX
Data
Financials
Upcoming Events
News
|
|||||
|---|---|---|---|---|---|
| Prev. Close | $515.15 |
|
|||
| Open | $515.15 | ||||
| 52 Wk High | $117.84 | ||||
| 52 Wk Low | $63.48 | ||||
| Day High | $515.15 | ||||
| Day Low | $515.15 | ||||
| P/E | 148.03 | ||||
| EPS | $3.48 | ||||
| Volume | 101 | ||||
- Form 4 IDEXX LABORATORIES INC For: Aug 20 Filed by: Emerson Andrew
- IDEXX Laboratories (IDXX) Reiterated at Buy by Stifel as Fundamentals Remain Intact
- IDEXX launches point-of-care cardiac test for cats and dogs
- IDEXX Expands Catalyst Platform into Cardiac Disease with First and Only Dual-Species Point-of-Care NT-proBNP Test
- IDEXX Laboratories (IDXX) PT Lowered to $710 at Barclays
- IDEXX Laboratories (IDXX) PT Raised to $670 at UBS
- Form 10-Q IDEXX LABORATORIES INC For: Jun 30
- Morgan Stanley: 'IDXX Shares Should Rise'
- IDEXX Labs (IDXX) Tops Q2 EPS by 31c ; Offers Guidance
- Form 8-K IDEXX LABORATORIES INC For: Aug 04
Entities mentioned with IDXX
- Earnings | View Related Stories »
- Definitive Agreement | View Related Stories »
- 13G | View Related Stories »
- Maynard Um | View Related Stories »
- Mark Zuckerberg | View Related Stories »
- ARK | View Related Stories »
- Stifel | View Related Stories »
- Trading Radar | View Related Stories »
- Show More...
